The mu opioid receptor A118G gene polymorphism moderates effects of trait anger-out on acute pain sensitivity
- PMID: 18579306
- PMCID: PMC2614266
- DOI: 10.1016/j.pain.2008.05.014
The mu opioid receptor A118G gene polymorphism moderates effects of trait anger-out on acute pain sensitivity
Abstract
Both trait anger-in (managing anger through suppression) and anger-out (managing anger through direct expression) are related to pain responsiveness, but only anger-out effects involve opioid mechanisms. Preliminary work suggested that the effects of anger-out on postoperative analgesic requirements were moderated by the A118G single nucleotide polymorphism of the mu opioid receptor gene. This study further explored these potential genotypexphenotype interactions as they impact acute pain sensitivity. Genetic samples and measures of anger-in and anger-out were obtained in 87 subjects (from three studies) who participated in controlled laboratory acute pain tasks (ischemic, finger pressure, thermal). McGill Pain Questionnaire (MPQ) Sensory and Affective ratings for each pain task were standardized within studies, aggregated across pain tasks, and combined for analyses. Significant anger-outxA118G interactions were observed (p's<.05). Simple effects tests for both pain measures revealed that whereas anger-out was nonsignificantly hyperalgesic in subjects homozygous for the wild-type allele, anger-out was significantly hypoalgesic in those with the variant G allele (p's<.05). For the MPQ-Affective measure, this interaction arose both from low pain sensitivity in high anger-out subjects with the G allele and heightened pain sensitivity in low anger-out subjects with the G allele relative to responses in homozygous wild-type subjects. No genetic moderation was observed for anger-in, although significant main effects on MPQ-Affective ratings were noted (p<.005). Anger-in main effects were due to overlap with negative affect, but anger-outxA118G interactions were not, suggesting unique effects of expressive anger regulation. Results support opioid-related genotypexphenotype interactions involving trait anger-out.
Figures



Similar articles
-
Pain-related effects of trait anger expression: neural substrates and the role of endogenous opioid mechanisms.Neurosci Biobehav Rev. 2009 Mar;33(3):475-91. doi: 10.1016/j.neubiorev.2008.12.003. Epub 2008 Dec 25. Neurosci Biobehav Rev. 2009. PMID: 19146872 Free PMC article. Review.
-
Anger regulation style, postoperative pain, and relationship to the A118G mu opioid receptor gene polymorphism: a preliminary study.J Behav Med. 2006 Apr;29(2):161-9. doi: 10.1007/s10865-005-9030-7. Epub 2006 Jan 7. J Behav Med. 2006. PMID: 16400534
-
Trait anger expressiveness and pain-induced beta-endorphin release: support for the opioid dysfunction hypothesis.Pain. 2007 Aug;130(3):208-215. doi: 10.1016/j.pain.2006.11.013. Epub 2007 Jan 2. Pain. 2007. PMID: 17197088 Free PMC article. Clinical Trial.
-
The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans.J Pain. 2005 Mar;6(3):159-67. doi: 10.1016/j.jpain.2004.11.008. J Pain. 2005. PMID: 15772909
-
[Postoperative pain management following orthognathic surgery in consideration of individual differences--is the antinociceptive effect of fentanyl related to the genotype involving nucleotide at OPRM1?].Masui. 2009 Sep;58(9):1102-8. Masui. 2009. PMID: 19764432 Review. Japanese.
Cited by
-
Pain-related effects of trait anger expression: neural substrates and the role of endogenous opioid mechanisms.Neurosci Biobehav Rev. 2009 Mar;33(3):475-91. doi: 10.1016/j.neubiorev.2008.12.003. Epub 2008 Dec 25. Neurosci Biobehav Rev. 2009. PMID: 19146872 Free PMC article. Review.
-
Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection.Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):15079-84. doi: 10.1073/pnas.0812612106. Epub 2009 Aug 14. Proc Natl Acad Sci U S A. 2009. PMID: 19706472 Free PMC article.
-
Neuropsychological Functions of μ- and δ-Opioid Systems.ISRN Addict. 2013 Dec 26;2013:674534. doi: 10.1155/2013/674534. eCollection 2013. ISRN Addict. 2013. PMID: 25938117 Free PMC article. Review.
-
Impact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot study.J Addict Med. 2015 Mar-Apr;9(2):130-5. doi: 10.1097/ADM.0000000000000107. J Addict Med. 2015. PMID: 25622123 Free PMC article. Clinical Trial.
-
Genetic Variation A118G in the OPRM1 Gene Underlies the Dimorphic Response to Epidural Opioid-Induced Itch.Neurosci Bull. 2025 May 17. doi: 10.1007/s12264-025-01411-6. Online ahead of print. Neurosci Bull. 2025. PMID: 40381142
References
-
- Aiken LS, West SG. Multiple regression: Testing and interpreting interactions. Thousand Oaks, CA: Sage; 1991.
-
- Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psych. 1986;51:1173–1182. - PubMed
-
- Beck AT, Ward CH, Mendelson M, Mock JE, Erbough JK. An inventory for measuring depression. Archives of General Psychiatry. 1961;4:561–571. - PubMed
-
- Beutler LE, Engle D, Oro-Beutler E, Daldrup R, Meredith K. Inability to express intense affect: a common link between depression and pain. J Consult Clin Psychol. 1986;54:752–759. - PubMed
-
- Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schluger J, Strong JA, Leal SM, Tischfield JA, Kreek MJ, Yu L. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA. 1998;95:9608–9613. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials